cro.directory
← Compare landing

Ergomed Clinical Research vs Scimega Research

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryErgomed Clinical ResearchScimega Research
SummaryErgomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.Canadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Regulatory Affairs
Modalities
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
Data not yet provided.
Indications
  • Oncology
  • Rare Disease
  • Oncology
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Phase I
  • Phase II
  • Phase III
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Headquarters, Raleigh, North Carolina, United States
  • Operational Hub, Boston, Massachusetts, United States
  • Laval, Laval, Québec, Canada
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Ergomed Clinical Research alternatives · Scimega Research alternatives

Markdown mirror: /compare/medsource/scimega.md